OR WAIT null SECS
March 15, 2020
This article returns to the topic of complying with pharmacopoeial requirements with a case study at the intersection of monograph development and compliance.
February 17, 2020
An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.
February 02, 2020
Researching excipient grades and sources, as well as screening suppliers and materials, form the basis of programs to mitigate risk.
December 15, 2019
The revision process and the resulting publication of proposed and official updates for pharmacopoeias around the world are described.
This article describes the revision process and the resulting publication of proposed and official updates for pharmacopoeias around the world.
An effective surveillance program for monitoring the activities of pharmacopoeias around the world requires processes, people, and tools from across a company.
An understanding of global and national pharmacopoeias is crucial to understanding change processes and access to different markets.
The process used to monitor and participate in pharmacopoeial changes is described.
Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.
Find links to pertinent regulatory and standard setting resources, guidance documents, and guidelines.